Mainz Biomed (MYNZ) Accounts Payables (2020 - 2025)
Historic Accounts Payables for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $2.3 million.
- Mainz Biomed's Accounts Payables fell 2792.77% to $2.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.3 million, marking a year-over-year decrease of 2792.77%. This contributed to the annual value of $2.3 million for FY2024, which is 2792.77% down from last year.
- According to the latest figures from Q4 2024, Mainz Biomed's Accounts Payables is $2.3 million, which was down 2792.77% from $3.2 million recorded in Q4 2023.
- In the past 5 years, Mainz Biomed's Accounts Payables registered a high of $3.2 million during Q4 2023, and its lowest value of $399137.0 during Q4 2020.
- For the 5-year period, Mainz Biomed's Accounts Payables averaged around $1.9 million, with its median value being $2.3 million (2024).
- As far as peak fluctuations go, Mainz Biomed's Accounts Payables skyrocketed by 24624.33% in 2022, and later crashed by 2792.77% in 2024.
- Over the past 5 years, Mainz Biomed's Accounts Payables (Quarter) stood at $399137.0 in 2020, then skyrocketed by 96.62% to $784786.0 in 2021, then skyrocketed by 246.24% to $2.7 million in 2022, then rose by 17.19% to $3.2 million in 2023, then dropped by 27.93% to $2.3 million in 2024.
- Its Accounts Payables stands at $2.3 million for Q4 2024, versus $3.2 million for Q4 2023 and $2.7 million for Q4 2022.